Education
About Us
Working with TipRanks
Follow Us
Bonus Biogroup Ltd. (IL:BONS)
:BONS
BONS Stock Chart & Stats
21.40
>-0.01(-5.03%)
At close: 4:00 PM EST
21.40
>-0.01(-5.03%)
Day’s Range― - ―
52-Week Range9.00 - 27.40
Previous CloseN/A
Volume3.65M
Average Volume (3M)1.16M
Market Cap
$255.78M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.20M
Total Debt (Recent Filing)$9.60M
Price to Earnings (P/E)―
Beta1.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,167,925,300
10 Day Avg. Volume838,885
30 Day Avg. Volume1,162,235
Financial Highlights & Ratios
PEG Ratio1.84
Price to Book (P/B)18.13
Price to Sales (P/S)0.00
P/FCF Ratio-5.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bonus Biogroup News
BONS FAQ
What was Bonus Biogroup Ltd.’s price range in the past 12 months?
Bonus Biogroup Ltd. lowest stock price was 9.00 and its highest was 27.40 in the past 12 months.
What is Bonus Biogroup Ltd.’s market cap?
Bonus Biogroup Ltd.’s market cap is $255.78M.
When is Bonus Biogroup Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bonus Biogroup Ltd.’s earnings last quarter?
Currently, no data Available
Is Bonus Biogroup Ltd. overvalued?
According to Wall Street analysts Bonus Biogroup Ltd.’s price is currently Overvalued.
Does Bonus Biogroup Ltd. pay dividends?
Bonus Biogroup Ltd. does not currently pay dividends.
What is Bonus Biogroup Ltd.’s EPS estimate?
Bonus Biogroup Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bonus Biogroup Ltd. have?
Bonus Biogroup Ltd. has 1,167,925,300 shares outstanding.
What happened to Bonus Biogroup Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bonus Biogroup Ltd.?
Currently, no hedge funds are holding shares in IL:BONS
Company Description
Bonus Biogroup Ltd.
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-threatening acute inflammatory diseases. Its products in pipeline comprise bone augmentation in osteoporosis patients; novel nano-materials for drug delivery; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.